Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Although often conflated, determining the best treatment for an individual (the task of a doctor) is fundamentally different from determining the average effect of treatment in a population (the purpose of a trial). In this paper, we review concepts of heterogeneity of treatment effects (HTE) essential in providing the evidence base for precision medicine and patient-centred care, and explore some inherent limitations of using group data (e.g. from a randomized trial) to guide treatment decisions for individuals. We distinguish between person-level HTE (i.e. that individuals experience different effects from a treatment) and group-level HTE (i.e. that subgroups have different average treatment effects), and discuss the reference class problem, engendered by the large number of potentially informative subgroupings of a study population (each of which may lead to applying a different estimated effect to the same patient), and the scale dependence of group-level HTE. We also review the limitations of conventional 'one-variable-at-a-time' subgroup analyses and discuss the potential benefits of using more comprehensive subgrouping schemes that incorporate information on multiple variables, such as those based on predicted outcome risk. Understanding the conceptual underpinnings of HTE is critical for understanding how studies can be designed, analysed, and interpreted to better inform individualized clinical decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating causal effects of treatments in randomized and nonrandomized studies
Rubin, D. B. (1974) · Journal of Educational Psychology · doi:10.1037/h0037350 · Cited by 9,436
Statistics and Causal Inference
Holland, P. W. (1986) · Journal of the American Statistical Association · doi:10.1080/01621459.1986.10478354 · Cited by 5,293 · cited 1×
“This is a consequence of the fundamental problem of causal inference: only one of the potential outcomes can be observed for a given patient whereas outcomes under other treatments remain counterfactual.(6) Thus, person-level treatment effects cannot be identified, even in large well-conducted randomized trials (with…”
BackgroundA New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914 · cited 1×
“There is broad agreement across published recommendations that subgroups be fully defined a priori (to prevent data dredging), that they be limited in number, that formal tests for interaction be performed (using an appropriate test procedure and possibly corrected for multiple comparisons) and that results should be…”
BackgroundROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859 · cited 1×
“Even in a randomized study, differences in the treatment effect over a subgrouping variable may be due to uncontrolled relationships between the variable, factors for which it operates as a proxy, and the outcome.(30,33,34) For example, if acute stroke patients with extreme hypertension are shown to 2186 International…”
BackgroundIs a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808 · cited 1×
“There is broad agreement across published recommendations that subgroups be fully defined a priori (to prevent data dredging), that they be limited in number, that formal tests for interaction be performed (using an appropriate test procedure and possibly corrected for multiple comparisons) and that results should be…”
BackgroundSubgroup analyses in randomized trials: risks of subgroup-specific analyses;
Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheran, P. A., & Peters, T. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.009 · Cited by 775 · cited 1×
“In general, HTE analyses require a much larger sample size compared with analyses of the overall effect, to have reasonable power.(25,36,37) The problem of low power is exacerbated when variables that have small influence on the treatment effect individually are evaluated one at a time; underpowered subgroup analyses…”
Background
Cited by
Schandelmaier, S., Briel, M., Varadhan, R., Schmid, C. H., Devasenapathy, N., Hayward, R. A., Gagnier, J., Borenstein, M., van der Heijden, G. J. M. G., Dahabreh, I. J., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200077 · Cited by 749
Self-citationPersonalized evidence based medicine: predictive approaches to heterogeneous treatment effects
Kent, D. M., Steyerberg, E., & van Klaveren, D. (2018) · BMJ · doi:10.1136/bmj.k4245 · Cited by 479
Self-citationThe Predictive Approaches to Treatment effect Heterogeneity (PATH) statement
Kent, D. M., Paulus, J. K., van Klaveren, D., D'Agostino, R., Goodman, S., Hayward, R., Ioannidis, J. P. A., Patrick-Lake, B., Morton, S., Pencina, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m18-3667 · Cited by 469
Self-citationMayer, A., Zimmermann, J., Hoyer, J., Salzer, S., Wiltink, J., Leibing, E., & Leichsenring, F. (2020) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705511.2019.1671196 · Cited by 21
Metadata
- Authors
- Dahabreh, I. J., Hayward, R., & Kent, D. M.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-17
- Volume
- 45
- Issue
- 6
- Pages
- dyw125
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2554140069
- Cited by
- 132
- References
- 19
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. https://app.cochat.ai/papers/10.1093/ije/dyw125
- The paper
- Dahabreh, I. J., Hayward, R., & Kent, D. M. (2016). Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyw125
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.